A phase I study of G3139 antisense oligonucleotide (oblimersen) in combination with CHOP [cyclophosphamide + doxorubicin + vincristine + prednisone] and rituximab in untreated advanced stage diffuse large B cell lymphoma
Phase of Trial: Phase I
Latest Information Update: 14 Apr 2009
At a glance
- Drugs Oblimersen (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Rituximab; Vincristine
- Indications B cell lymphoma
- Focus Adverse reactions
- 25 Oct 2007 Status changed from in progress to completed.
- 09 Sep 2005 New trial record.